Teppei Okamoto

23PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNeurology and neuromuscular diseasesMedical mycologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 14, 2026
Treatment Patterns and Outcomes After Recurrence Following Adjuvant Nivolumab for Urothelial Carcinoma: An AGEHA Real-World Study.

|Aug 15, 2026
Visualizing Baseline Eligibility Across Locally Advanced or Metastatic Urothelial Cancer Trials and Real-World Cohorts.

|Mar 23, 2026
Association of Prophylactic Intravenous Corticosteroid Premedication With Toxicity and Survival in Patients Receiving Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma.

Masanao Shinohara, Hayato Yamamoto, Yohei Kawashima

|Mar 08, 2026
Overactive Bladder Symptoms as a Predictor of Longitudinal Decline in Grip Strength in Community-Dwelling Men: A 4-Year Longitudinal Study.

Hiroyuki Sato, Teppei Okamoto, Tomoko Hamaya

|Jul 03, 2025
A Case of Delayed Refractory Mycobacterium mageritense Abdominal Wall Abscess in a Kidney Transplant Recipient.

Hisashi Sakurai, Teppei Okamoto, Tomoko Hamaya

|Jun 28, 2025
Serum Serotonin Levels as a Potential Risk Factor for Overactive Bladder in a Community-Dwelling Population: A Four-Year Longitudinal Study.

Takafumi Fukushima, Teppei Okamoto, Tomoko Hamaya

Pageof 4

Frequent Collaborators

13 joint publications

Shingo Hatakeyama

7 joint publications

Naoki Fujita

4 joint publications

Hayato Yamamoto

3 joint publications

Shintaro Narita